China · Delayed Price · Currency is CNY Nanjing Vazyme Biotech Statistics
Total Valuation
SHA:688105 has a market cap or net worth of CNY 10.08 billion. The enterprise value is 8.23 billion.
| Market Cap | 10.08B |
| Enterprise Value | 8.23B |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Jun 3, 2026 |
Share Statistics
SHA:688105 has 516.99 million shares outstanding. The number of shares has increased by 26.30% in one year.
| Current Share Class | 516.99M |
| Shares Outstanding | 516.99M |
| Shares Change (YoY) | +26.30% |
| Shares Change (QoQ) | -65.43% |
| Owned by Insiders (%) | 14.85% |
| Owned by Institutions (%) | 10.77% |
| Float | 175.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 94.47 |
| PS Ratio | 6.85 |
| PB Ratio | 2.80 |
| P/TBV Ratio | 2.97 |
| P/FCF Ratio | 46.64 |
| P/OCF Ratio | 39.48 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 150.50, with an EV/FCF ratio of 38.09.
| EV / Earnings | n/a |
| EV / Sales | 5.59 |
| EV / EBITDA | 150.50 |
| EV / EBIT | n/a |
| EV / FCF | 38.09 |
Financial Position
The company has a current ratio of 3.99, with a Debt / Equity ratio of 0.19.
| Current Ratio | 3.99 |
| Quick Ratio | 3.53 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 12.28 |
| Debt / FCF | 3.11 |
| Interest Coverage | -6.46 |
Financial Efficiency
Return on equity (ROE) is -0.50% and return on invested capital (ROIC) is -3.72%.
| Return on Equity (ROE) | -0.50% |
| Return on Assets (ROA) | -0.85% |
| Return on Invested Capital (ROIC) | -3.72% |
| Return on Capital Employed (ROCE) | -1.78% |
| Weighted Average Cost of Capital (WACC) | 7.58% |
| Revenue Per Employee | 490,377 |
| Profits Per Employee | -2,925 |
| Employee Count | 3,002 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 1.28 |
Taxes
| Income Tax | -12.95M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.72% in the last 52 weeks. The beta is 0.68, so SHA:688105's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +11.72% |
| 50-Day Moving Average | 19.97 |
| 200-Day Moving Average | 16.80 |
| Relative Strength Index (RSI) | 43.61 |
| Average Volume (20 Days) | 13,556,754 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688105 had revenue of CNY 1.47 billion and -8.78 million in losses. Loss per share was -0.02.
| Revenue | 1.47B |
| Gross Profit | 1.00B |
| Operating Income | -67.36M |
| Pretax Income | -31.65M |
| Net Income | -8.78M |
| EBITDA | 29.72M |
| EBIT | -67.36M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 2.51 billion in cash and 671.57 million in debt, with a net cash position of 1.84 billion or 3.56 per share.
| Cash & Cash Equivalents | 2.51B |
| Total Debt | 671.57M |
| Net Cash | 1.84B |
| Net Cash Per Share | 3.56 |
| Equity (Book Value) | 3.60B |
| Book Value Per Share | 19.23 |
| Working Capital | 2.53B |
Cash Flow
In the last 12 months, operating cash flow was 255.35 million and capital expenditures -39.19 million, giving a free cash flow of 216.16 million.
| Operating Cash Flow | 255.35M |
| Capital Expenditures | -39.19M |
| Depreciation & Amortization | 97.08M |
| Net Borrowing | -529.24M |
| Free Cash Flow | 216.16M |
| FCF Per Share | 0.42 |
Margins
Gross margin is 68.11%, with operating and profit margins of -4.58% and -0.60%.
| Gross Margin | 68.11% |
| Operating Margin | -4.58% |
| Pretax Margin | -2.15% |
| Profit Margin | -0.60% |
| EBITDA Margin | 2.02% |
| EBIT Margin | -4.58% |
| FCF Margin | 14.68% |
Dividends & Yields
This stock pays an annual dividend of 0.38, which amounts to a dividend yield of 1.90%.
| Dividend Per Share | 0.38 |
| Dividend Yield | 1.90% |
| Dividend Growth (YoY) | 261.12% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -26.30% |
| Shareholder Yield | -24.40% |
| Earnings Yield | -0.09% |
| FCF Yield | 2.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for SHA:688105 is 18.80, which is -3.59% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | 18.80 |
| Price Target Difference | -3.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 18.35% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on June 3, 2026. It was a forward split with a ratio of 1.3.
| Last Split Date | Jun 3, 2026 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |